Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by trial titles, indicators and specific disease types.

Bladder Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Colon Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Esophageal Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Fallopian Tube Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

GI Stromal Tumor (GIST)

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Liver Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: Non-Hodgkins
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Renal Cancer

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Dallas

Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism (39039039STM4001)

  • Details

ClinicalTrials.gov ID: NCT02555878
Diagnosis Type: NA
USOR Number: 15026

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, TX 75231
P: (214) 739-4175

More Details View Practice Page

Pages